OnBioVC » X – Muscular Dystrophy

OnBioVC » X – Muscular Dystrophy http://onbiovc.wordpress.com From the A to the Exit: What is Happening in Bio VC Sun, 20 Jan 2008 01:12:53 +0000 http://wordpress.com/ en hourly 1 http://www.gravatar.com/blavatar/4a13f5ce7669f680a629e5b66974f131?s=96&d=http://s.wordpress.com/i/buttonw-com.png OnBioVC » X – Muscular Dystrophy http://onbiovc.wordpress.com Prosensa Holding BV: Series A $18M http://onbiovc.wordpress.com/2007/02/14/prosensa-holding-bv-series-a-18m/ http://onbiovc.wordpress.com/2007/02/14/prosensa-holding-bv-series-a-18m/#comments Wed, 14 Feb 2007 20:50:00 +0000 arubenstein http://onbiovc.wordpress.com/2007/02/14/prosensa-holding-bv-series-a-18m/ ]]>

Prosensa (Netherlands) a biotech company focused on RNA interference therapeutics for muscular dystrophies raised $18 million in Series A funding. The deal was led by Abingworth Management and Life Science Partners and were joined by return backer Medsciences Capital.

]]> http://onbiovc.wordpress.com/2007/02/14/prosensa-holding-bv-series-a-18m/feed/ 0 arubenstein